Evaluation of the effect of 9.5/11.5-fr ureteral access sheath use on acute kidney injury with the myo-inositol oxygenase biomarker in patients undergoing retrograde intrarenal surgery: a prospective, randomized, and controlled study

Basit Öğe Kaydı
dc.contributor.authorTuran, Abdullah
dc.contributor.authorHirik, Erkan
dc.contributor.authorErdogan, Abdullah
dc.contributor.authorAltun, Abdulsemet
dc.contributor.authorMertoglu, Cuma
dc.contributor.authorSam, Emre
dc.contributor.authorAtar, Muhittin
dc.date.accessioned2025-02-22T14:08:55Z
dc.date.available2025-02-22T14:08:55Z
dc.date.issued2025
dc.departmentDicle Üniversitesien_US
dc.description.abstractIntroductionWe aimed to investigate whether a low intrarenal pressure provided by ureteral access sheath (UAS) use had a positive effect on the prevention of acute kidney injury through the evaluation of the myo-inositol oxygenase (MIOX).Material and methodsThe patients were divided into two groups according to whether a 9.5/11.5-Fr UAS was used during retrograde intrarenal surgery (RIRS): UAS group and non-UAS group. RIRS was performed under gravity irrigation and manual pumping was not used. For the measurement of MIOX, 5 cc blood samples were taken from the patients preoperatively and four hours postoperatively.ResultsOperation time and hospital stay were significantly longer in the UAS group. The mean preoperative and postoperative MIOX values were 0.77 +/- 0.36 ng/ml and 0.74 +/- 0.38 ng/ml, respectively, in the UAS group, and 0.74 +/- 0.31 ng/ml and 0.83 +/- 0.40 ng/ml, respectively, in the non-UAS group. The mean MIOX change was -0.29 +/- 0.36 in the UAS group and 0.08 +/- 0.44 in the non-UAS group, indicating no significant difference between the groups.ConclusionEven if UAS is not used, significant acute kidney injury is not observed under gravity irrigation and therefore, if we avoid manual pumping, the intrarenal pressure remains low, thus potentially rendering the use of 9,5/11,5-Fr UAS unnecessary.en_US
dc.identifier.doi10.1080/13645706.2024.2340730
dc.identifier.endpage7en_US
dc.identifier.issn1364-5706
dc.identifier.issn1365-2931
dc.identifier.issue1en_US
dc.identifier.pmid38651905en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage1en_US
dc.identifier.urihttps://doi.org/10.1080/13645706.2024.2340730
dc.identifier.urihttps://hdl.handle.net/11468/29715
dc.identifier.volume34en_US
dc.identifier.wosWOS:001206914200001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherTaylor & Francis Ltden_US
dc.relation.ispartofMinimally Invasive Therapy & Allied Technologiesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmzKA_WOS_20250222
dc.subjectKidney stoneen_US
dc.subjectretrograde intrarenal surgeryen_US
dc.subjectureteral access sheathen_US
dc.subjectmyo-inositol oxygenase (MIOX)en_US
dc.titleEvaluation of the effect of 9.5/11.5-fr ureteral access sheath use on acute kidney injury with the myo-inositol oxygenase biomarker in patients undergoing retrograde intrarenal surgery: a prospective, randomized, and controlled studyen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu